Literature DB >> 2040632

Localization of type I iodothyronine 5'-deiodinase to the basolateral plasma membrane in renal cortical epithelial cells.

J L Leonard1, D M Ekenbarger, S J Frank, A P Farwell, J Koehrle.   

Abstract

Type I iodothyronine 5'-deiodinase is an integral membrane protein catalyzing the phenolic ring deiodination of thyroxine. We recently showed that the substrate binding subunit of this approximately 50-kDa protein is selectively labeled with N-bromoacetyl-L-thyroxine, allowing ready identification of the type I enzyme without the need to maintain catalytic activity. In this study, we used both affinity labeling and catalytic activity to determine the regional distribution of this enzyme in rat kidney and to localize the enzyme to specific plasma membrane domain(s) of renal epithelial cells. The type I enzyme was present exclusively in tubular epithelial cells of the outer renal cortex and co-purified with basolateral plasma membranes; the renal medulla lacked activity. LLC-PK1 cells, derived from the proximal convoluted tubule, have abundant type I 5'-deiodinating activity. We used this homogenous cell line to verify that the type I enzyme was localized to the cytosolic surface of the basolateral membrane. Digitonin permeabilization increased affinity labeling of the enzyme 4-fold, and approximately 75% of the affinity label was incorporated into the 27-kDa substrate binding subunit. Affinity labeling of the type I enzyme in LLC-PK1 cells mimicked the affinity labeling of the substrate binding subunit of type I 5'-deiodinase in rat kidney (Köhrle, J., Rasmussen, U. B., Ekenbarger, D. M., Alex, S., Rokos, H., Hesch, R. D., and Leonard, J. L. (1990) J. Biol. Chem. 265, 6155-6163). Subcellular fractionation of LLC-PK1 cell homogenates showed that both affinity labeled and catalytically active type I enzyme were present on the cytosolic surface of the basolateral region of the renal cell membrane.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2040632

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Type I 5'-iodothyronine deiodinase activity and mRNA are remarkably reduced in renal clear cell carcinoma.

Authors:  J Pachucki; M Ambroziak; Z Tanski; J Luczak; J Nauman; A Nauman
Journal:  J Endocrinol Invest       Date:  2001-04       Impact factor: 4.256

2.  Type 3 lodothyronine deiodinase: cloning, in vitro expression, and functional analysis of the placental selenoenzyme.

Authors:  D Salvatore; S C Low; M Berry; A L Maia; J W Harney; W Croteau; D L St Germain; P R Larsen
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

3.  Differential selenium-dependent expression of type I 5'-deiodinase and glutathione peroxidase in the porcine epithelial kidney cell line LLC-PK1.

Authors:  M Gross; M Oertel; J Köhrle
Journal:  Biochem J       Date:  1995-03-15       Impact factor: 3.857

4.  Selenium Deficiency-Induced Damage and Altered Expression of Mitochondrial Biogenesis Markers in the Kidneys of Mice.

Authors:  Hehuan Lai; Tingting Nie; Yitong Zhang; Ying Chen; Jiaqi Tao; Tingting Lin; Tangdong Ge; Fenglan Li; Hui Li
Journal:  Biol Trace Elem Res       Date:  2020-03-14       Impact factor: 3.738

5.  Dynamic PET and SPECT imaging with radioiodinated, amyloid-reactive peptide p5 in mice: a positive role for peptide dehalogenation.

Authors:  Emily B Martin; Stephen J Kennel; Tina Richey; Craig Wooliver; Dustin Osborne; Angela Williams; Alan Stuckey; Jonathan S Wall
Journal:  Peptides       Date:  2014-08-04       Impact factor: 3.750

6.  A Peptide-Fc Opsonin with Pan-Amyloid Reactivity.

Authors:  James S Foster; Angela D Williams; Sallie Macy; Tina Richey; Alan Stuckey; Daniel Craig Wooliver; Richa Koul-Tiwari; Emily B Martin; Stephen J Kennel; Jonathan S Wall
Journal:  Front Immunol       Date:  2017-09-04       Impact factor: 7.561

7.  Evaluation of the effect of D-amino acid incorporation into amyloid-reactive peptides.

Authors:  Emily B Martin; Angela Williams; Tina Richey; Craig Wooliver; Alan Stuckey; James S Foster; Stephen J Kennel; Jonathan S Wall
Journal:  J Transl Med       Date:  2017-12-11       Impact factor: 5.531

8.  Secondary structure propensity and chirality of the amyloidophilic peptide p5 and its analogues impacts ligand binding - In vitro characterization.

Authors:  Jonathan S Wall; Angela Williams; Craig Wooliver; Emily B Martin; Xiaolin Cheng; R Eric Heidel; Stephen J Kennel
Journal:  Biochem Biophys Rep       Date:  2016-08-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.